These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 16627811)

  • 1. Identification of a novel C5L2 variant (S323I) in a French Canadian family with familial combined hyperlipemia.
    Marcil M; Vu H; Cui W; Dastani Z; Engert JC; Gaudet D; Castro-Cabezas M; Sniderman AD; Genest J; Cianflone K
    Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1619-25. PubMed ID: 16627811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S323I polymorphism of the C5L2 gene was not identified in a Chinese population with familial combined hyperlipidemia or with type 2 diabetes.
    Zheng YY; Xie X; Ma YT; Yang YN; Fu ZY; Li XM; Liu F; Yang SJ; Ma X; Chen BD
    Genet Mol Res; 2011 Dec; 10(4):3256-66. PubMed ID: 22194190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C5a- and ASP-mediated C5L2 activation, endocytosis and recycling are lost in S323I-C5L2 mutation.
    Cui W; Simaan M; Laporte S; Lodge R; Cianflone K
    Mol Immunol; 2009 Sep; 46(15):3086-98. PubMed ID: 19615750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between type 2 diabetes mellitus and a novel polymorphism C698T in C5L2 in the Chinese Han population.
    Zheng YY; Xie X; Ma YT; Yang YN; Fu ZY; Li XM; Ma X; Chen BD; Liu F
    Endocrine; 2012 Apr; 41(2):296-301. PubMed ID: 22180093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acylation-stimulating protein/C5L2-neutralizing antibodies alter triglyceride metabolism in vitro and in vivo.
    Cui W; Paglialunga S; Kalant D; Lu H; Roy C; Laplante M; Deshaies Y; Cianflone K
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1482-91. PubMed ID: 17711993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C5L2 is a functional receptor for acylation-stimulating protein.
    Kalant D; MacLaren R; Cui W; Samanta R; Monk PN; Laporte SA; Cianflone K
    J Biol Chem; 2005 Jun; 280(25):23936-44. PubMed ID: 15833747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant C3adesArg/acylation stimulating protein (ASP) is highly bioactive: a critical evaluation of C5L2 binding and 3T3-L1 adipocyte activation.
    Cui W; Lapointe M; Gauvreau D; Kalant D; Cianflone K
    Mol Immunol; 2009 Oct; 46(16):3207-17. PubMed ID: 19767107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E polymorphism influences lipid phenotypic expression, but not the low density lipoprotein subfraction distribution in familial combined hyperlipidemia.
    Bredie SJ; Vogelaar JM; Demacker PN; Stalenhoef AF
    Atherosclerosis; 1996 Oct; 126(2):313-24. PubMed ID: 8902157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The chemoattractant receptor-like protein C5L2 binds the C3a des-Arg77/acylation-stimulating protein.
    Kalant D; Cain SA; Maslowska M; Sniderman AD; Cianflone K; Monk PN
    J Biol Chem; 2003 Mar; 278(13):11123-9. PubMed ID: 12540846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic evidence from 7 families that the apolipoprotein B gene is not involved in familial combined hyperlipidemia.
    Rauh G; Schuster H; Müller B; Schewe S; Keller C; Wolfram G; Zöllner N
    Atherosclerosis; 1990 Jul; 83(1):81-7. PubMed ID: 1975179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between a novel polymorphism of the C5L2 gene and coronary artery disease.
    Zheng YY; Xie X; Ma YT; Yang YN; Fu ZY; Li XM; Ma X; Chen BD; Liu F
    PLoS One; 2011; 6(6):e20984. PubMed ID: 21698200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E R112; R251G: a carboxy-terminal variant found in patients with hyperlipidemia and coronary heart disease.
    Kang AK; Jenkins DJ; Wolever TM; Huff MW; Maguire GF; Connelly PW; Hegele RA
    Mutat Res; 1997 Sep; 382(1-2):57-65. PubMed ID: 9360638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel mutation in C5L2 gene was associated with hyperlipidemia and retinitis pigmentosa in a Chinese family.
    Qu LH; Jin X; Li LM; Li SY; Xie HP
    Lipids Health Dis; 2014 May; 13():75. PubMed ID: 24885523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between genetic variation at the APO AI-CIII-AIV gene cluster and familial combined hyperlipidaemia.
    Xu CF; Talmud P; Schuster H; Houlston R; Miller G; Humphries S
    Clin Genet; 1994 Dec; 46(6):385-97. PubMed ID: 7889654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a new apolipoprotein E5 variant detected in two French-Canadian subjects.
    Mailly F; Xu CF; Xhignesse M; Lussier-Cacan S; Talmud PJ; Davignon J; Humphries SE; Nestruck AC
    J Lipid Res; 1991 Apr; 32(4):613-20. PubMed ID: 1713245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial hypercholesterolemia: molecular, biochemical, and clinical characterization of a French-Canadian pediatric population.
    Assouline L; Levy E; Feoli-Fonseca JC; Godbout C; Lambert M
    Pediatrics; 1995 Aug; 96(2 Pt 1):239-46. PubMed ID: 7630677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of the APOLIPOPROTEIN A1/C3/A4/A5 gene cluster with triglyceride levels and LDL particle size in familial combined hyperlipidemia.
    Mar R; Pajukanta P; Allayee H; Groenendijk M; Dallinga-Thie G; Krauss RM; Sinsheimer JS; Cantor RM; de Bruin TW; Lusis AJ
    Circ Res; 2004 Apr; 94(7):993-9. PubMed ID: 15001527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High frequency of a retinoid X receptor gamma gene variant in familial combined hyperlipidemia that associates with atherogenic dyslipidemia.
    Nohara A; Kawashiri MA; Claudel T; Mizuno M; Tsuchida M; Takata M; Katsuda S; Miwa K; Inazu A; Kuipers F; Kobayashi J; Koizumi J; Yamagishi M; Mabuchi H
    Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):923-8. PubMed ID: 17272748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum complement and familial combined hyperlipidemia.
    Ylitalo K; Porkka KV; Meri S; Nuotio I; Suurinkeroinen L; Vakkilainen J; Pajukanta P; Viikari JS; Peltonen L; Ehnholm C; Taskinen MR
    Atherosclerosis; 1997 Mar; 129(2):271-7. PubMed ID: 9105570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two polymorphisms in the apo A-IV gene and familial combined hyperlipidemia.
    Groenendijk M; De Bruin TW; Dallinga-Thie GM
    Atherosclerosis; 2001 Oct; 158(2):369-76. PubMed ID: 11583715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.